Immunological Markers in Amniotic Fluid as Predictors of Respiratory Distress Syndrome in Extremely Preterm Infants

FULL TEXT:

Abstract

Respiratory distress syndrome (RDS) in newborns is a breathing disorder occurring in the first days of life, caused by a primary surfactant deficiency and pulmonary immaturity. The incidence of RDS in newborns is inversely proportional to gestational age. It occurs in 92% of cases at 24–25 weeks of gestation, 88% at 26–27 weeks, 76% at 28–29 weeks, 57% at 30–31 weeks, and in less than 5% of preterm infants born after 34 weeks of gestation. This indicates that the clinical management of infants with RDS remains a significant and largely unresolved challenge. Aim. The objective of this study was to evaluate the prognostic value of interleukins (IL) 6 and 8 in amniotic fluid regarding the development of respiratory distress syndrome (RDS) in extremely preterm infants. Materials and methods: The study included 58 women who gave birth and their extremely preterm infants, born at a gestational age of 22–32 weeks. The main group consisted of 38 infants with RDS, while the control group comprised 20 extremely preterm infants without clinical signs of respiratory distress. Samples of amniotic fluid and umbilical cord blood were collected from all the mothers to determine the concentrations of IL-6 and IL-8. Amniotic fluid was collected under aseptic conditions during the rupture of membranes in labor or during a cesarean section; only samples free of blood contamination were used for analysis. The concentrations of IL-6 and IL-8 were measured via enzyme-linked immunosorbent assay (ELISA) using the "Interleukin-6-ELISA-BEST" and "Interleukin-8-ELISA-BEST" kits (JSC "Vector-Best," Novosibirsk). Results: In the main group, the level of IL-6 in the amniotic fluid was 3.4 times higher than in the control group (88.9 ± 3.73 vs. 26.1 ± 1.54 pg/mL). The level of IL-8 was slightly lower (20.2 ± 1.1 vs. 24.3 ± 1.3 pg/mL). Infants with RDS had a lower gestational age (27.4 ± 2.3 vs. 30.6 ± 2.6 weeks). Among the pregnancy complications observed in the mothers of children in the study group were gestational hypertension (41.3%), preeclampsia (12%), eclampsia (8%), and grade I–II diffuse goiter (44.4%). Conclusion: IL-6 levels in amniotic fluid may serve as a prognostic marker for respiratory distress syndrome (RDS) in extremely preterm infants. Further research is required to evaluate its diagnostic value.

About the Authors

List of references

Наврузова Ш.И., Юлдашева Г.Г. Эффективность терапии сурфактантом у недоношенных детей с респираторным дистресс-синдромом. Navruzova SH.I., Yuldasheva G.G. Effektivnost' terapii surfaktantom u nedonoshennykh detey s respiratornym distress-sindromom // International Journal of Scientific Pediatrics. 2022. С. 14–19. URL: https://cyberleninka.ru/article/n/effektivnost-terapii-surfaktantom-u-nedonoshennyh-detey-s-respiratornym-distress-sindromom

Сурфактанты у новорождённого: что нового? (Сателлитный симпозиум компании «Натива» в рамках XXI Всероссийского научно-образовательного форума «Мать и дитя») // Эффективная фармакотерапия. Акушерство и гинекология. Poverkhnostno-aktivnyye veshchestva v novorozhdonnom: chto novogo? (Satellitnyy simpozium kompanii «Nativa» v ramkakh XXI Vserossiyskogo nauchno-obrazovatel'nogo foruma «Mat' i ditya») // Effektivnaya farmakoterapiya. Akusherstvo i ginekologiya 2020. Т. 16, №28. RL:https://umedp.ru/articles/surfaktanty_u_novorozhdennogo_chto_novogo_xxi_vserossiyskiy_nauchnoobrazovatelnyy_forum_mat_i_ditya_.html

Эффективность препарата экзогенного сурфактанта берактант (Сюрванта) у новорождённых с респираторным дистресс-синдромом и первые результаты применения в Российской Федерации. /Володин Н.Н., Гребенников И.А., Милева О.И., Бабак О.А., Петрова А.С., Воронцова Ю.Н., Кршеминская И.В., Овсянников Д.Ю. // Педиатрия. Журнал им. Г.Н. Сперанского. 2018. Т. 97, № 1. С. 106–114. Effektivnost' prigotovleniya ekzogennogo surfaktanta beraktanta (Syuvanta) u novorozhdonnykh s respiratornym distress-sindromom i pervyye rezul'taty primeneniya v Rossiyskoy Federatsii. /Volodin N.N., Grebennikov I.A., Mileva O.I., Babak O.A., Petrova A.S., Vorontsova YU.N., Krsheminskaya I.V., Ovsyannikov D.YU. // Pediatriya. Zhurnal im. G.N. Speranskogo. 2018. T. 97, № 1. S. 106–114.DOI: 10.24110/0031-403X-2018-97-1-106-114

Yuldasheva G.G., Bakhranova N.R., Baratov S.S. Statistical analysis of the structure of the birth rate of underweight children in the Bukhara region // Art of Medicine. International Medical Scientific Journal. 2021. № 5. P. 21–26.

Фомина М.П. Цитокиновый статус околоплодных вод и пуповинной крови при рождении маловесных детей // Медицинские новости. 2015. № 8. С. 78–83. Fomina M.P. Tsitokinovyy status okoloplodnykh vod i pupovinnoy krovi pri svete malovesnykh detey // Meditsinskiye novosti. 2015. № 8. S. 78–83. URL: https://cyberleninka.ru/article/n/tsitokinovyy-status-okoloplodnyh-vod-i-pupovinnoy-krovi-pri-rozhdenii-malovesnyh-detey

European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update /Sweet D.G., Carnielli V.P., Greisen G. et al. // Neonatology. 2023. Vol. 120, № 1. P. 3–23. DOI: 10.1159/000528914

How to Cite

Immunological Markers in Amniotic Fluid as Predictors of Respiratory Distress Syndrome in Extremely Preterm Infants. (2026). International Journal of Scientific Pediatrics, 5(6), 1500-1505. https://doi.org/10.56121/2181-2926-2026-5-6-1500-1505

Similar Articles

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)


ISSN 2181-2926 (Online)